Drug profile · INN
prednisolone acetate
OMNIPRED
prednisolone acetate (OMNIPRED) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — prednisolone acetate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
prednisolone acetate (OMNIPRED) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prednisolone acetate?
prednisolone acetate (OMNIPRED) is a glucocorticoid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for prednisolone acetate?
OMNIPRED is a marketed brand name for prednisolone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prednisolone acetate?
prednisolone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.